| Dear Voornaam,
Welcome to your weekly Cancer Research UK Research Update email.
I’m pleased to share news about our new research data strategy with you today.
Data science is key to answering many of the important questions in discovery, prevention, detection and treatment research, and achieving the objectives we set out in our research strategy.
Our new strategy sets out how we will scale up our activity and ensure we are grasping the ever-growing opportunities to use data science wisely and fairly to generate maximum insight from research data and samples.
We’re already supporting research in data science, and over the coming months we are developing exemplar research programmes, with dedicated funding for data science projects to follow.
We will also launch a state-of-the-art, interoperable Trusted Research Environment so that innovative high-priority research collaborations involving cancer data can be done in a safe, secure and reliable environment.
We’ve worked closely with people affected by cancer throughout to ensure that we are always acting in the very best interests of people who will benefit from this work and can advocate for the secure and responsible use of patient and public data to strengthen the UK’s R&D environment for data science.
Thank you to everyone who provided their insights to help us develop this strategy. Your support is vital to achieving our goals as we work together to build a stronger cancer data science community.
Also in this email, and amidst all the political upheaval of the last few days, our policy team analyses the latest government clinical research implementation plan and asks, can it succeed?
Kind regards,
Iain
Iain Foulkes
Executive Director Research & Innovation
CEO Cancer Research Horizons
Cancer Research UK
|
|
|---|
|
|---|
|
|
FUNDING AND RESEARCH OPPORTUNITIES |
|
|---|
|
|---|
| | | Applications accepted all-year round |
|
|---|
|
|---|
|
|
RESEARCH DATA STRATEGY LAUNCH We’ve published our new research data strategy – a deeper exploration of data science following our research strategy refresh. |
|
|---|
| | “We intend to solve the challenges and realise the patient benefits of secure data-sharing"
Big data is becoming a vital tool to beat cancer. However, our ability to generate cancer-relevant data has outpaced our capability to effectively use it. To capitalise on the full value of data will need a joined-up approach... |
|
|---|
|
|---|
|
|
GOING BEYOND RECOVERY Is the UK government’s vision for clinical research on track?
Joe Kiely from our policy team looks at the latest implementation plan for clinical research to see what the government has planned for some of the £5bn allocated to health research in the latest Spending Review. Will it make a difference for the recovery of clinical research impacted by COVID-19? |
|
|---|
| HOW ARE FUNDING DECISIONS MADE? We recently invited early career researchers to observe some of our panel discussions and committees.
So, how did they get on and what did they learn? Sweta Sharma Saha, Ahsan Akram and Rebecca Landy shared what they found out. |
|
|---|
|
|---|
|
|
DISCOUNTED TICKETS FOR THE EARLY DETECTION OF CANCER CONFERENCE: 18–20 OCTOBER After 2 years of virtual meetings, the Early Detection of Cancer Conference is back in person in Portland from 18–20 October.
We have 30 discounted tickets up for grabs for UK researchers. Use code UK20EDx at checkout for 20% off registration. These tickets are first-come, first-served, so be quick if you want to secure one.
We’re also providing 5 complimentary registrations and travel bursaries for UK-based students and postdocs whose abstracts are selected for the conference. Submit an abstract by 19 August to be considered for a lightning talk, with general abstract submission closing on 2 September. |
|
|---|
|
|---|
|
|
JOIN US IN AMSTERDAM FOR MAP 2022: 14–16 OCTOBER This is a must-attend meeting for every cancer researcher – basic, translational or clinical – interested in cancer complexity and the mechanisms behind it.
Submissions are open for practice-changing and clinically relevant abstracts – including those that go beyond traditional topics and highlight emerging technologies for cancer profiling.
100 travel grants are also available to first authors under 40. Submit by 26 July for the chance to be selected. |
|
|---|
|
|---|
|
|
REGISTER NOW FOR THE BLACK IN CANCER CONFERENCE: 10–11 OCTOBER The abstract deadline is coming up – don’t miss out on the opportunity to showcase your work. You have until 22 July to submit a poster abstract in 1 of 3 scientific areas – basic biology, clinical trials and translation.
If you’re a postdoc or student, you may also be chosen to present your research as part of our Future Leaders session. The conference will be held in London and is relevant for all scientists across the research pipeline, and at all career stages.
Join us for scientific sessions, panel discussions and workshops on the themes of research, equality and patient experience. |
|
|---|
|
|---|
|
|
| | | London, UK 05 September 2022 |
|
|---|
|
|---|
| | | Cambridge, UK 20 September 2022 |
|
|---|
|
|---|
| | | London, UK 10 October 2022 |
|
|---|
|
|---|
| | | Amsterdam, Netherlands 14 October 2022 |
|
|---|
|
|---|
| | | Portland, Oregon, USA 18 October 2022 |
|
|---|
|
|---|
| | | Manchester, UK 15 November 2022 |
|
|---|
|
|---|
| | | East Sussex, UK 04 December 2022 |
|
|---|
|
|---|
|
|
WHAT DID YOU THINK OF THIS EMAIL? We're always looking for ways to improve. Please give us your feedback by clicking below and leaving a comment. |
|
|---|
|
|---|
|
|
| Been forwarded this email?
Subscribe to our newsletter to stay up-to-date. |
|---|
| |
|---|
|
|
|
